ProShare Advisors LLC Sells 170,332 Shares of Colgate-Palmolive Company $CL

ProShare Advisors LLC decreased its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 8.1% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,934,035 shares of the company’s stock after selling 170,332 shares during the period. ProShare Advisors LLC owned about 0.24% of Colgate-Palmolive worth $165,012,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also made changes to their positions in CL. Vise Technologies Inc. boosted its holdings in Colgate-Palmolive by 10.4% in the third quarter. Vise Technologies Inc. now owns 82,381 shares of the company’s stock worth $7,029,000 after acquiring an additional 7,755 shares in the last quarter. Investment Partners LTD. grew its stake in shares of Colgate-Palmolive by 45.7% during the third quarter. Investment Partners LTD. now owns 5,715 shares of the company’s stock worth $488,000 after purchasing an additional 1,792 shares in the last quarter. Summit Global Investments boosted its stake in Colgate-Palmolive by 12.5% during the 3rd quarter. Summit Global Investments now owns 116,574 shares of the company’s stock worth $9,946,000 after purchasing an additional 12,991 shares during the period. Aprio Wealth Management LLC lifted its holdings in Colgate-Palmolive by 5.6% in the third quarter. Aprio Wealth Management LLC now owns 12,570 shares of the company’s stock valued at $1,072,000 after acquiring an additional 672 shares during the period. Finally, State of Wyoming purchased a new position in Colgate-Palmolive during the third quarter worth $258,000. 80.41% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Colgate-Palmolive

In other news, Director John Cahill sold 4,170 shares of the firm’s stock in a transaction that occurred on Thursday, August 6th. The shares were sold at an average price of $93.37, for a total value of $389,352.90. Following the transaction, the director owned 28,373 shares in the company, valued at approximately $2,649,187.01. This trade represents a 12.81% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO Panagiotis Tsourapas sold 10,000 shares of the business’s stock in a transaction that occurred on Monday, August 24th. The shares were sold at an average price of $92.05, for a total value of $920,500.00. Following the transaction, the chief operating officer directly owned 64,901 shares in the company, valued at $5,974,137.05. This trade represents a 13.35% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 175,191 shares of company stock worth $16,110,903. 0.43% of the stock is currently owned by insiders.

Trending Headlines about Colgate-Palmolive

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Third-quarter adjusted earnings were $0.97 per share, above the roughly $0.92–$0.93 analyst consensus and up from $0.91 a year earlier. Revenue increased 4.6% year over year to $5.37 billion, also exceeding expectations. Colgate-Palmolive Surpasses Q3 Earnings and Revenue Estimates
• Positive Sentiment: Organic sales growth, pricing, higher volumes and productivity initiatives supported the quarterly beat. Management raised its 2026 base-business EPS and gross-margin outlook, signaling better profitability despite cost pressures. Colgate Q3 Earnings Beat Estimates on Organic Sales and Pricing Gains
• Positive Sentiment: The company maintained its fiscal 2026 EPS outlook while improving its base-business profitability forecast. The stronger guidance likely explains the favorable investor reaction and elevated trading activity. Colgate-Palmolive Raises FY26 Base-Business EPS View
• Neutral Sentiment: Management narrowed its full-year sales-growth outlook, suggesting that pricing and productivity—not broad-based demand—remain important drivers of performance. Colgate-Palmolive Raises Profit Outlook Despite Weak US Demand
• Negative Sentiment: Weak U.S. demand and rising input costs remain risks. The earnings beat was strong, but investors may question how sustainable margin gains will be if consumer demand softens or cost inflation accelerates. Colgate-Palmolive Q3 Analysis

Colgate-Palmolive Stock Up 2.4%

CL stock opened at $95.35 on Friday. Colgate-Palmolive Company has a 12 month low of $74.54 and a 12 month high of $99.33. The stock has a market capitalization of $76.01 billion, a P/E ratio of 37.39, a price-to-earnings-growth ratio of 4.61 and a beta of 0.33. The company has a current ratio of 1.03, a quick ratio of 0.67 and a debt-to-equity ratio of 13.82. The firm has a 50-day moving average price of $89.54 and a 200-day moving average price of $89.65.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, October 30th. The company reported $0.97 EPS for the quarter, beating analysts’ consensus estimates of $0.93 by $0.04. Colgate-Palmolive had a net margin of 9.68% and a return on equity of 464.63%. The business had revenue of $5.37 billion during the quarter, compared to analyst estimates of $5.34 billion. During the same quarter in the previous year, the business posted $0.91 EPS. Colgate-Palmolive’s quarterly revenue was up 4.6% on a year-over-year basis. As a group, equities research analysts anticipate that Colgate-Palmolive Company will post 3.89 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Tuesday, October 20th will be given a $0.53 dividend. The ex-dividend date is Tuesday, October 20th. This represents a $2.12 dividend on an annualized basis and a yield of 2.2%. Colgate-Palmolive’s payout ratio is presently 84.13%.

Analysts Set New Price Targets

A number of equities analysts have commented on CL shares. Piper Sandler cut their price objective on shares of Colgate-Palmolive from $98.00 to $95.00 and set an “overweight” rating on the stock in a report on Monday, September 21st. Raymond James Financial increased their target price on shares of Colgate-Palmolive from $100.00 to $102.00 and gave the company an “outperform” rating in a research note on Monday, August 3rd. Bank of America cut their price target on shares of Colgate-Palmolive from $102.00 to $100.00 and set a “buy” rating on the stock in a report on Friday, October 9th. UBS Group set a $106.00 price objective on shares of Colgate-Palmolive in a research note on Thursday, October 15th. Finally, Weiss Ratings lowered shares of Colgate-Palmolive from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday, October 2nd. Thirteen investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $98.56.

About Colgate-Palmolive

Colgate-Palmolive Company (NYSE: CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwash, liquid hand soap, body wash, deodorants, household cleaning products and pet food and treats.

The company markets well-known brands such as Colgate, Palmolive, elmex, meridol, Softsoap, Irish Spring, Ajax, Protex and Hill’s Science Diet. Colgate-Palmolive also provides veterinary and nutritional products through Hill’s Pet Nutrition, which serves pet owners and animal health professionals.

Founded in 1806 by William Colgate, the company developed from a soap and candle business into a diversified consumer goods manufacturer.